Mode
Text Size
Log in / Sign up

Home-based e-based exercise protocol feasibility study for patients with multiple sclerosis and comorbiditiesWorking Out From Home Could Slow Multiple Sclerosis Progression

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that primary efficacy outcomes are pending as this is a feasibility protocol for a future RCT.

The study design involves a feasibility study with 50 participants and a prospective randomized controlled trial (RCT) protocol planned for 300 participants. The population includes pwMS with and without comorbidities, receiving a home-based e-based physical exercise program supervised online by physiotherapists. The comparator is usual care. The intervention consists of resistance training with resistance bands targeting the lower extremities, delivered as two 60-minute sessions per week for 24 weeks.

Feasibility results indicate a recruitment rate of 91.3% (21 of 23 eligible participants enrolled). Follow-up completion was 76.2% (16 of 21 enrolled participants completed follow-up). Mean attendance was 15.2 sessions per participant, ranging from 6 to 22 sessions. The adherence rate was 63%. Two participants in the intervention group did not begin the program due to occupational constraints. No intervention-related adverse events were reported during the feasibility phase.

Primary efficacy outcomes, specifically changes in walking capacity using the 6-minutes' walk test, have not yet been reported as this publication is a protocol. Secondary outcomes include the NEDA-3 scale, quality of life measures, fatigue, and neurofilament light chain levels. Key limitations include the feasibility-only nature of current data and recruitment constraints related to occupational factors. Causality regarding the e-based exercise program's effect on outcomes is to be evaluated in the upcoming prospective RCT. Safety data is currently limited to adverse events observed during the feasibility study.

When MS and Other Conditions Collide

Living with multiple sclerosis (MS) is hard enough on its own. But most people with MS also manage at least one other chronic condition — things like diabetes, heart disease, or depression.

That combination can make exercise feel impossible. And yet exercise is one of the best tools doctors have for managing MS symptoms.

Why Exercise Keeps Getting Overlooked

MS affects roughly 2.8 million people worldwide. It damages the nerves that control movement, balance, and energy. Over time, it can make walking harder and fatigue overwhelming.

Doctors have known for years that physical activity helps. But getting to a gym when you're exhausted, or when balance is unreliable, is a real barrier.

The Old Way vs. What's Being Tried Now

Traditional exercise programs for MS patients usually happen in clinics or rehab centers. That requires transportation, scheduling, and energy many patients simply don't have.

But here's the twist: what if the gym came to you?

This trial uses resistance bands — stretchy bands that create resistance when you pull or push against them. Think of them like a portable gym that fits in a drawer.

Participants follow a structured lower-body workout twice a week, for 60 minutes each session, from their own home. A physiotherapist watches and guides the group over a video call. It's like a fitness class on your laptop, with a medical expert in the room.

The COMPACT trial will include 300 adults with MS — half assigned to the exercise program, half to standard care. The trial runs for 24 weeks (about six months). A smaller feasibility test already ran with 50 people to make sure the approach was practical.

In the preliminary phase, 21 out of 23 people assigned to exercise actually started the program. That's a 91% start rate — unusually high for exercise studies.

Of those who started, 76% completed follow-up assessments. On average, participants attended about 15 of 24 sessions. No exercise-related injuries or adverse events were reported. Those early numbers suggest this kind of program is safe and achievable for people with MS.

That's Not the Full Story

The main trial hasn't started yet — these are just early feasibility results.

The full trial will look at changes in walking speed and distance, quality of life, fatigue levels, and even biological markers of nerve damage in the blood. Those results will take at least another year to arrive.

Why This Approach Makes Sense

Researchers in this field have argued for years that digital health tools could close the gap between what's recommended and what's actually accessible. This trial is designed to test that idea in a rigorous way.

The fact that the program targets people with MS and other conditions is important. Most exercise studies exclude people with comorbidities — leaving doctors with little guidance for the patients who need it most.

If you or someone you know has MS, this research is worth watching. But the program is not yet available outside the trial. If you're interested in exercise for MS symptom management, talk to your neurologist or a physiotherapist about what's currently available to you.

This is a protocol paper, not a results paper. The feasibility phase was small (50 people), and we don't yet know whether the exercise program will actually improve MS outcomes. Adherence at 63% is reasonable but not perfect — and the full trial will need to achieve similar or better numbers.

What Comes Next

The full 300-person randomized controlled trial is now underway. When results are published — likely in 2026 or 2027 — they could provide strong evidence for whether home-based online exercise should become a standard option for people managing MS alongside other conditions.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
BackgroundComorbidity is prevalent among people with multiple sclerosis (pwMS) and may contribute to disease progression. Physical exercise (PE) reduces symptoms in pwMS and also benefits comorbidities. Digital (e)-based PE has been proposed as a tool to support the integration of PE.AimsTo describe a protocol for a randomized controlled trial (RCT) based on a structured approach and the results from a controlled feasibility study of an e-based PE intervention in pwMS with and without comorbidities.MethodIn a RCT following a feasibility study (n=50), patients will be randomly assigned in a 1:1 ratio to receive either usual care (n=150) or usual care plus an e-based PE program at home (n=150). The exercise program consists of resistance training with resistance bands targeting the lower extremities. The sessions will enable participants to engage in group exercises from their homes, supervised online by physiotherapists, two 60-minute sessions per week for 6 months (24 weeks and 48 sessions). The primary endpoint is change of walking capacity using the 6-minutes’ walk test. Secondary endpoints include “no evidence of disease activity” (NEDA)-3 scale, measures of quality of life and fatigue as well as levels of neurofilament light chain in blood and cerebrospinal fluid.Results of the feasibility study: Fifty individuals were eligible and randomized to an intervention group (n = 23) or to a usual care control group (n = 27). A total of 24 sessions were conducted for three months in groups of 6, supervised by the physiotherapist. In the intervention group, two pwMS did not begin the PE program due to occupational constraints with a resulting recruitment rate of 91.3% (21/23). Of the remaining 21 individuals, 16 (76.2%) completed the follow-up assessments with a mean attendance of 15.2 (range 6-22) sessions per participant, corresponding to a 63% adherence rate. No intervention‐related adverse events were reported.ConclusionThis protocol describes a prospective RCT study and the supporting feasibility data of an e-based PE performed at home. The effects of e-based PE performed at home will be evaluated, offering a significant contribution to the field of digital healthcare solutions and MS.Clinical Trial Registrationhttps://clinicaltrials.gov/, identifier NCT06298201.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.